Rubber tourniquet
ProcedureThe blood sample is taken with a rubber tourniquet
NCT Number: NCT05226364
This prospective study evaluates the effect of abstaining from tourniquets on pain reduction during the venous puncture of the elderly people.
Looking for future studies?
Notify Me75 year and older
All sexes
Interventional
Not applicable
Geriatric Department - CHRU Brest, Brest, France
Almost 3 million people aged 70 and over are hospitalized once or more each year. The implementation of multiple treatments in these fragile patients, often poly-pathological requires a regular biological monitoring. For these patients, samples must be taken on average every two days.
This population often has a fragile venous capital due to reduced skin elasticity, undernutrition more or less associated with dehydration, the use of certain venous-toxic treatments and / or repetition of the gesture taking into account the monitoring biological closely related to long-term therapies.
With the aim of well-treatment and well-being, the reduction of patient pain is one of the major concerns of caregivers and in particular pain induced by treatment.
In children, the practice of harvesting without tourniquet is already frequent (18) and our preliminary study has confirmed us on the tourniquet as one of the acts responsible for the pain that the caregiver can possibly abstain.
No study had been conducted on this subject in the adult population and more particularly the elderly population. This prospective study evaluates the effect of abstaining from tourniquets on pain reduction during the venous puncture of the elderly people.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The blood sample is taken with a rubber tourniquet
The blood sample is taken with a fabric tourniquet
The blood sample is taken without tourniquet
Time frame: At the end of the study, an average of 12 month
Assessment of maximum pain on examination (including pain from skin-vascular invasion and tourniquet pain)by the patient using a verbal numerical scale (EN) rated from 0 to 10.
This measure concerns the 1st sampling as a whole, regardless of the number of attempts necessary to obtain it and their terms
Time frame: At the end of the study, an average of 12 month
Estimate of the proportion of patients corresponding to phlebological prerequisites of the study (vein visible or palpable on at least one of the two upper limbs) on all elderly people meeting the other selection criteria upon admission to the service for the duration of the research
Time frame: At the end of the study, an average of 12 month
Compilation of the number of cutaneous-vascular ruptures performed until obtention of a sample sent to laboratory
Time frame: At the end of the study, an average of 12 month
Measurement of the time required for this sample using timing from the moment the nurse is ready and until the end of the filling of the first tube sampled. This timing is performed by the caregiver himself and not by the third party who will collect the patient's pain and who is not present, in order to avoid any external influence linked to the performance of the gesture during the evaluation of the main criterion
Time frame: At the end of the study, an average of 12 month
Collection of the ease of performing the sampling by the caregivers via a Likert-type question (very easy, rather easy, rather difficult, very difficult) filled in after each sampling.
In addition, the need to change arms or to call on another caregiver to perform the procedure will be noted.
Time frame: At the end of the study, an average of 12 month
Verbal numerical scale measurements of tourniquet pain and pain due to vascular break (groups with tourniquet only).
0 = No pain, 5 = moderate pain and 10 = Worst possible pain.
Time frame: At the end of the study, an average of 12 month
The presence of hematoma (s) will be observed in each group the next day of the sample by a caregiver separate from the one who performed the sample. The caregiver will also note the presence of skin abrasions related to possible use of tourniquet. Other unwanted events will also be collected, in particular: vagal unease during or after the sample, hemorrhage, ...
Time frame: At the end of the study, an average of 12 month
Proportion of samples having to be carried out again for hemolysis
Time frame: At the end of the study, an average of 12 month
Estimation of the effect of the mode of venipuncture (arm), according to the experience of the nurse on the duration of blood collection.
The duration of the blood sampling is expressed in minute.
Time frame: At the end of the study, an average of 12 month
Estimation of the effect of the mode of venipuncture (arm), according to the experience of the nurse on pain.
Verbal numerical scale measurements was used : 0 = No pain, 5 = moderate pain and 10 = Worst possible pain.
Time frame: At the end of the study, an average of 12 month
Estimation of the effect of the mode of venipuncture (arm), according to the type of material (butterfly needle, diameter) on pain.
Verbal numerical scale measurements was used : 0 = No pain, 5 = moderate pain and 10 = Worst possible pain.
Time frame: At the end of the study, an average of 12 month
Estimation of the effect of the mode of venipuncture (arm), according to the type of material (butterfly needle, diameter) on the duration of blood collection.
The duration of the blood sampling is expressed in minute.
Time frame: At the end of the study, an average of 12 month
Number of failures (regardless of the venous sampling method used) and refusal of the sample venous without tourniquet
Hôpital NOVO
Other
Effect of Tourniquet Abstention on Pain Reduction in Venous Sampling in the Elderly People : Randomized Trial
Acronym: NO-GARROT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05688384
Behavior, Cancer
Jönköping, Sweden
View Trial DetailsNCT05453305
Anxiety Disorders, Disease Attributes
Zaragoza, Spain
View Trial DetailsNCT04185233
Anxiety, Anxiety Disorders
Geneva, Switzerland
View Trial DetailsNCT06290284
Disease Attributes, Emergencies
Milan, Italy
View Trial Details